GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Gallbladder and Pancreas/Immediate Necrosectomy Accelerates Recovery in Walled-Off Necrosis : Gastroenterology | Jul 2026

Immediate Necrosectomy Accelerates Recovery in Walled-Off Necrosis : Gastroenterology | Jul 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated July 1, 2026

Quick Answer

Introduction: Endoscopic ultrasound (EUS)-guided drainage has become the preferred minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain.


Introduction:

Endoscopic ultrasound (EUS)-guided drainage has become the preferred minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves necrosectomy for patients who fail to improve after drainage alone, some experts advocate earlier intervention to accelerate resolution of infected or symptomatic necrosis.

Problem Statement:

Although the step-up strategy minimizes procedural interventions, delayed necrosectomy may prolong inflammation, hospital stay, and recovery. Whether immediate DEN following EUS-guided drainage improves clinical outcomes without increasing complications has not been established in prospective randomized trials.

Summary:

The WONDER-01 trial is the first randomized study to directly compare immediate DEN with a drainage-oriented step-up strategy in patients undergoing endoscopic treatment for symptomatic necrotizing pancreatitis. The study demonstrated that immediate necrosectomy significantly shortened the time to clinical success, resulting in faster reduction of necrotic collections and earlier resolution of systemic inflammation. Patients receiving immediate DEN achieved recovery approximately two weeks earlier than those managed with the conventional step-up approach. Importantly, this benefit was achieved without an increase in procedure-related adverse events, mortality, or technical failure. As expected, all patients in the immediate intervention arm underwent necrosectomy, whereas less than half of patients in the step-up group ultimately required the procedure, highlighting the trade-off between faster recovery and greater procedural utilization. The findings suggest that early removal of necrotic debris may accelerate disease resolution in appropriately selected patients while maintaining a favorable safety profile. However, because many patients managed with drainage alone avoided necrosectomy altogether, treatment decisions should remain individualized. Overall, this landmark trial provides evidence that immediate DEN after EUS-guided drainage can shorten recovery time without compromising safety. The results challenge the traditional step-up paradigm and support consideration of earlier necrosectomy in selected patients with symptomatic walled-off necrosis, while emphasizing the need to balance procedural burden against potential clinical benefit.

Related Q&A

Ivonescimab Plus Gemcitabine–Cisplatin in Biliary Tract Cancer (BTC): Journal of Hepatology | July 2026

Introduction: Advanced biliary tract cancer (BTC) carries a poor prognosis, with limited improvements in survival despite the addition of immune checkpoint inhibitors to standard gemcitabine–cisplatin chemotherapy. This phase II trial evaluated ivonescimab, a novel PD-1/VEGF...

GLP-1 Receptor Agonists and Gallbladder Disease: UEG Journal | June 2026

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a cornerstone in the management of type 2 diabetes because of their excellent glycemic, cardiovascular, and weight-loss benefits. However, concerns remain regarding their potential association with...

Remnant Duct Dilatation Rarely Signals IPMN Recurrence : Ann Surg | Jun 2026

Introduction: Patients undergoing pancreatoduodenectomy for non invasive intraductal papillary mucinous neoplasm (IPMN) require long-term surveillance because of the risk of disease recurrence in the pancreatic remnant. New pancreatic duct (PD) dilatation is commonly detected during...

Post-Pancreatectomy Chyle Leak: Annals of Surgery | June 2026

• This study evaluated 1,063 patients undergoing pancreatic surgery; 11% developed conventionally defined chyle leak. • Most clinically relevant cases were grade B, while no grade C leaks were reported. • A minimally invasive surgical...

Fatty Pancreas: A Hidden Burden in T2DM : Diabetes Res Clin Pract | June 2026

Introduction: Fatty pancreas disease (FPD), also known as intrapancreatic fat deposition, has emerged as an important metabolic condition closely linked to obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). Although ectopic fat accumulation in...

Selective Use of Biliary Drainage Supported in pCCA : BJS | Jun 2026

Introduction: Preoperative biliary drainage (PBD) is frequently used in patients with perihilar cholangiocarcinoma (pCCA) to relieve biliary obstruction before surgery. The proposed benefits include improved liver function, reduced jaundice, and optimization of the future liver...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer